TLR7 and neoplasm: This innovative approach, through the co-delivery of the PS Ce6 and cholesterol-bound R848 (Chol-R848) to tumor sites, not only triggers ICD via Ce6-mediated PDT but also specifically targets TLR7/8 within the tumor (Figure 2).